Onward Medical Bv Stock Price To Sales
| 63E Stock | 4.51 0.07 1.53% |
ONWARD MEDICAL BV fundamentals help investors to digest information that contributes to ONWARD MEDICAL's financial success or failures. It also enables traders to predict the movement of ONWARD Stock. The fundamental analysis module provides a way to measure ONWARD MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ONWARD MEDICAL stock.
ONWARD |
ONWARD MEDICAL BV Company Price To Sales Analysis
ONWARD MEDICAL's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, ONWARD MEDICAL BV has a Price To Sales of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
ONWARD Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ONWARD MEDICAL's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ONWARD MEDICAL could also be used in its relative valuation, which is a method of valuing ONWARD MEDICAL by comparing valuation metrics of similar companies.ONWARD MEDICAL is currently under evaluation in price to sales category among its peers.
ONWARD Fundamentals
| Return On Equity | -2.89 | |||
| Return On Asset | -0.34 | |||
| Operating Margin | (19.04) % | |||
| Shares Owned By Insiders | 41.37 % | |||
| Shares Owned By Institutions | 39.43 % | |||
| Revenue | 1.78 M | |||
| Gross Profit | (10.58 M) | |||
| EBITDA | (33.44 M) | |||
| Book Value Per Share | 2.28 X | |||
| Earnings Per Share | (3.62) X | |||
| Number Of Employees | 76 | |||
| Market Capitalization | 34.4 M |
About ONWARD MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ONWARD MEDICAL BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ONWARD MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ONWARD MEDICAL BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ONWARD Stock
ONWARD MEDICAL financial ratios help investors to determine whether ONWARD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ONWARD with respect to the benefits of owning ONWARD MEDICAL security.